Globant S.A.
LUFinancials
Valuation Metrics
Globant S.A.'s Market Cap is $1.54B. At end of 2025 it was $2.92B. Ranked #2175 of 3,121 in US market (top 70%), #1317 of 1,658 on NYSE (top 79%), #206 of 275 in Software & Services (top 75%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.54B | US#2,175/3,121 Sec#206/275 |
| Revenue | $2.45B | US#1,326/3,121 Sec#102/275 |
| Net Income | $113M | US#1,574/3,121 Sec#120/275 |
| Total Assets | $3.23B | US#1,762/3,121 Sec#121/275 |
| Net Assets | $2.11B | US#1,203/3,121 Sec#80/275 |
| Employees | 28,510 | US#411/3,121 Sec#26/275 |
| Value | ||
| P/E | 13.56x | US#718/3,121 Sec#40/275 |
| P/B | 0.73x | US#197/3,121 Sec#13/275 |
| PEG | 12.56x | US#1,263/3,121 Sec#100/275 |
| P/S | 0.63x | US#447/3,121 Sec#33/275 |
| EV/EBITDA | 6.17x | US#312/3,121 Sec#19/275 |
| FCF Yield | 20.71% | US#169/3,121 Sec#21/275 |
| Profitability | ||
| ROE | 5.37% | US#1,806/3,121 Sec#143/275 |
| ROA | 3.51% | US#1,325/3,121 Sec#134/275 |
| Op. Margin | 8.23% | US#1,735/3,121 Sec#130/275 |
| Revenue Growth | -1.26% | US#2,327/3,121 Sec#244/275 |
| Earnings Growth | 1.08% | US#1,279/3,121 Sec#100/275 |
| Financial Health | ||
| Debt Ratio | 50.07% | US#570/3,121 Sec#51/275 |
| Total Debt | $518M | US#1,859/3,121 Sec#133/275 |
| FCF | $318M | US#1,131/3,121 Sec#108/275 |
| Cash | $164M | US#1,893/3,121 Sec#196/275 |
| Current Ratio | 1.84x | US#1,349/3,121 Sec#95/275 |
| Net Debt/EBITDA | 1.15x | US#1,024/3,121 Sec#118/275 |
| Performance | ||
| 1Y Return | -37.80% | US#2,688/3,121 Sec#196/275 |
| 1M Return | -9.89% | US#820/3,121 Sec#120/275 |
| From 52W High | -50.61% | US#2,657/3,121 Sec#204/275 |
| 1Y MDD | -61.06% | US#2,802/3,121 Sec#213/275 |
| Trading | ||
| Volume | 930,327 shares | US#1,534/3,121 Sec#165/275 |
| Trading Value | $34M | US#1,574/3,121 Sec#151/275 |
| Per Share | ||
| EPS | $2.63 | US#1,159/3,121 Sec#72/275 |
| BPS | $48.95 | US#457/3,121 Sec#18/275 |
Company Info
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development lifecycle; GUT Studio, which allows clients to better connect brands to end-consumers through experiential marketing; and Enterprise Studio, which leverages tailored technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, enabling industry-specific fine-tuning, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows that operate across systems, teams, and physical environments. Further, it provides various agentic suites, including GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, which enhances marketing, communications, and advertising with AI at the core, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. The company has a collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.